ARQT
Arcutis Biotherapeutics, Inc.
Approval
Confirmed
ZORYVE (roflumilast) Cream 0.3%
Plaque Psoriasis in children (age 2+)
146d ago
Jun 29, 2026
Press release
verified 5mo ago
Countdown card โ